BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5325 related articles for article (PubMed ID: 9164515)

  • 21. Confocal endomicroscopy in patients with ulcerative colitis.
    Watanabe O; Ando T; Maeda O; Hasegawa M; Ishikawa D; Ishiguro K; Ohmiya N; Niwa Y; Goto H
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S286-90. PubMed ID: 19120913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Colo-rectal precancerous conditions: anatomo-pathologic and clinical aspects].
    Melita P; Calbo L; Lemma F; Barbuscia M; Belnome NA; Palmeri R; Lorenzini C
    Chir Ital; 1984 Apr; 36(2):215-26. PubMed ID: 6525685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variation in the argyrophil cell population of the rectum in ulcerative colitis and adenocarcinoma.
    Gledhill A; Enticott ME; Howe S
    J Pathol; 1986 Aug; 149(4):287-91. PubMed ID: 2428963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study.
    Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI
    Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated c-Src tyrosine kinase activity in premalignant epithelia of ulcerative colitis.
    Cartwright CA; Coad CA; Egbert BM
    J Clin Invest; 1994 Feb; 93(2):509-15. PubMed ID: 7509341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometry and in vitro tritiated thymidine labeling in normal rectal mucosa of patients at high risk of colorectal cancer.
    Paganelli GM; Lalli E; Facchini A; Biasco G; Santucci R; Brandi G; Barbara L
    Am J Gastroenterol; 1994 Feb; 89(2):220-4. PubMed ID: 8304307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant potential of chronic ulcerative colitis. Preliminary report.
    Nugent FW; Haggit RC; Colcher H; Kutteruf GC
    Gastroenterology; 1979 Jan; 76(1):1-5. PubMed ID: 758130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Precancerous lesions of the colon and rectum].
    Igarashi T; Akimoto S; Otasiro Y; Hanyu F; Nagasako K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1639-44. PubMed ID: 2730060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
    Risio M; Candelaresi G; Rossini FP
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Possibility of different cancer development between the proximal and distal colon: comparison of the distribution between adenomatous polyps and cancer.
    Ikeda Y; Mori M; Koyanagi N; Minagawa S; Kondo N; Fujimaru R; Kojima Y; Kondo A; Sugimachi K
    Hepatogastroenterology; 1998; 45(23):1583-6. PubMed ID: 9840109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
    Markowitz J; McKinley M; Kahn E; Stiel L; Rosa J; Grancher K; Daum F
    Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of dysplasia in ulcerative colitis.
    Vatn MH; Elgjo K; Bergan A
    Scand J Gastroenterol; 1984 Oct; 19(7):893-5. PubMed ID: 6531658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deficiency of colonic telomerase in ulcerative colitis.
    Usselmann B; Newbold M; Morris AG; Nwokolo CU
    Am J Gastroenterol; 2001 Apr; 96(4):1106-12. PubMed ID: 11316155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential diagnosis of adenomas and dysplastic lesions in patients with ulcerative colitis.
    Schneider A; Stolte M
    Z Gastroenterol; 1993 Nov; 31(11):653-6. PubMed ID: 8291276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Labeling index in colonic cancer, polyps and polyposis and nonspecific colitis].
    Blokhina NG; Romanova LF; Kirkin BB; Markova EV; Chizhikov BA
    Vopr Onkol; 1986; 32(8):53-6. PubMed ID: 3765509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum and colon mucosa micronutrient antioxidants: differences between adenomatous polyp patients and controls.
    Nair S; Norkus EP; Hertan H; Pitchumoni CS
    Am J Gastroenterol; 2001 Dec; 96(12):3400-5. PubMed ID: 11774956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant correlation of morphological remodeling in ulcerative colitis with disease duration and between elevated p53 and p21 expression in rectal mucosa and neoplastic development.
    Mitsuhashi J; Mikami T; Saigenji K; Okayasu I
    Pathol Int; 2005 Mar; 55(3):113-21. PubMed ID: 15743319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial cell kinetics in the remaining colorectal mucosa after surgery for cancer of the large bowel.
    Scalmati A; Roncucci L; Ghidini G; Biasco G; Ponz de Leon M
    Cancer Res; 1990 Dec; 50(24):7937-41. PubMed ID: 2253235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 267.